Grunenthal Logo

External Link

You are now leaving the Grünenthal website. You will be re-directed to an external website. Grünenthal accepts no responsibility for the content of other websites.

Title
Description
Trial IDHP8824-01
CompoundDesogestrel 0,75mg
Trials sponsorLaboratorios Andromaco S.A.
Trial phase1
Brief titleBioavailability of Desogestrel 0.075 mg Tablets With Regards to Reference Product
IndicationContraception
UTN
CTG IDNCT04422028
CTIS ID (former EudraCT)
Trial statusCompleted
FPIDecember 27, 2019
LPOJanuary 28, 2020
CountriesGermany
GenderAll
Age18 Years to 55 Years
ResultsNo
Pubmed
Documents